DYRK1A and trisomy 21: Observations in mouse models with dosage imbalance of Dyrk1a lead to a hypothesis that a reduction of Dyrk1a, as in DYRK1A syndrome, and an increase of Dyrk1a, as in Trisomy 21, both cause skeletal deficits, providing a foundation for the study of these phenotypes in humans.